Regorafenib in GIST With Secondary C-KIT Exon 17 Mutation
NCT02606097
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
19
Enrollment
OTHER
Sponsor class
Conditions
Gastrointestinal Stromal Tumour (GIST)
Interventions
DRUG:
regorafenib
Sponsor
Chang Gung Memorial Hospital